Dianthus Therapeutics, Inc. (DNTH)
79.46
+0.13
(+0.16%)
USD |
NASDAQ |
Oct 27, 16:00
Dianthus Therapeutics Price : 79.46 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 77.87 | 79.90 | 77.05 | 79.33 | 501183.0 |
| Oct 23, 2026 | 76.03 | 78.16 | 76.02 | 76.78 | 379235.0 |
| Oct 22, 2026 | 77.13 | 78.96 | 75.40 | 78.53 | 1.480M |
| Oct 21, 2026 | 78.89 | 80.74 | 77.26 | 78.10 | 1.194M |
| Oct 20, 2026 | 74.61 | 79.93 | 73.16 | 78.75 | 1.865M |
| Oct 19, 2026 | 73.55 | 76.04 | 72.12 | 74.54 | 972522.0 |
| Oct 16, 2026 | 74.41 | 75.34 | 69.43 | 72.09 | 1.053M |
| Oct 15, 2026 | 75.77 | 77.55 | 72.67 | 74.53 | 943576.0 |
| Oct 14, 2026 | 77.17 | 78.78 | 74.47 | 74.76 | 977334.0 |
| Oct 13, 2026 | 81.42 | 81.46 | 77.25 | 77.58 | 1.315M |
| Oct 12, 2026 | 81.77 | 83.76 | 80.91 | 81.57 | 853947.0 |
| Oct 09, 2026 | 82.36 | 85.20 | 82.13 | 82.37 | 738872.0 |
| Oct 08, 2026 | 84.73 | 84.85 | 81.06 | 82.43 | 1.004M |
| Oct 07, 2026 | 84.60 | 86.61 | 84.13 | 84.88 | 562472.0 |
| Oct 06, 2026 | 88.58 | 88.58 | 83.18 | 85.40 | 1.348M |
| Oct 05, 2026 | 88.44 | 89.58 | 86.09 | 88.04 | 597421.0 |
| Oct 02, 2026 | 89.05 | 91.24 | 87.73 | 88.21 | 751386.0 |
| Oct 01, 2026 | 88.40 | 91.04 | 87.22 | 88.32 | 767034.0 |
| Sep 30, 2026 | 88.19 | 90.71 | 87.58 | 88.05 | 1.031M |
| Sep 29, 2026 | 87.40 | 87.69 | 84.72 | 87.16 | 1.034M |
| Sep 28, 2026 | 88.03 | 89.14 | 87.04 | 87.83 | 652710.0 |
| Sep 25, 2026 | 91.56 | 92.88 | 88.34 | 88.55 | 522725.0 |
| Sep 24, 2026 | 93.75 | 94.95 | 90.36 | 90.71 | 726361.0 |
| Sep 23, 2026 | 98.35 | 98.53 | 89.78 | 93.44 | 1.187M |
| Sep 22, 2026 | 96.84 | 100.47 | 96.55 | 98.35 | 1.127M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Verastem, Inc. | 10.09 |
| ACADIA Pharmaceuticals, Inc. | 20.16 |
| Alnylam Pharmaceuticals, Inc. | 226.74 |
| Anika Therapeutics, Inc. | 21.28 |
| Savara, Inc. | 4.86 |
Price Related Metrics
| PS Ratio | 1949.22 |
| PEG Ratio | -0.6941 |
| Price to Book Value | 3.715 |
| Earnings Yield | -5.23% |
| Market Cap | 4.354B |
| PEGY Ratio | -0.6941 |